Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Street

Showing results (201-210 of 241) with videos related to

Pageof 25
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
2,5-Dihydropyrazolo[4,3-c]pyridin-3-ones: functionally selective benzodiazepine binding site ligands on the GABAA receptorAndrew Mitchinson, John R Atack, Peter Blurton, et al.
Journal of Medicinal Chemistry|October 9, 2013
Structure-activity-relationship studies around the 2-amino group and pyridine core of antimalarial 3,5-diarylaminopyridines lead to a novel series of pyrazine analogues with oral in vivo activityYassir Younis, Frederic Douelle, Diego González Cabrera, et al.
Pharmacoeconomics|December 23, 2017
Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30Madeleine T King, Rosalie Viney, A Simon Pickard, et al.
Journal of Medicinal Chemistry|June 17, 2021
Benzoheterocyclic Oxime Carbamates Active against <i>Mycobacterium tuberculosis</i>: Synthesis, Structure-Activity Relationship, Metabolism, and Biology TriagingRenier van der Westhuyzen, Amanda Mabhula, Paul M Njaria, et al.
Journal of Psychopharmacology (Oxford, England)|February 12, 2010
MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humansJ R Atack, K A Wafford, L J Street, et al.
Journal of Medicinal Chemistry|March 19, 2004
3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1Robert W Carling, Kevin W Moore, Leslie J Street, et al.
Journal of Medicinal Chemistry|February 27, 2014
Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1Claire Le Manach, Diego Gonzàlez Cabrera, Frederic Douelle, et al.
Bioorganic & Medicinal Chemistry|November 3, 2015
Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterizationCandice Soares de Melo, Soares de Melo Candice, Tzu-Shean Feng, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2018
Synthesis and biological evaluation of aryl-oxadiazoles as inhibitors of Mycobacterium tuberculosisMaria Angeles Martinez-Grau, Isabel C Gonzalez Valcarcel, Julie V Early, et al.
Journal of Medicinal Chemistry|April 16, 2004
Selective, orally active gamma-aminobutyric acidA alpha5 receptor inverse agonists as cognition enhancersFrancine Sternfeld, Robert W Carling, Richard A Jelley, et al.
Pageof 25

Showing results (201-210 of 241) with videos related to

Sort By:
Pageof 25
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
2,5-Dihydropyrazolo[4,3-c]pyridin-3-ones: functionally selective benzodiazepine binding site ligands on the GABAA receptorAndrew Mitchinson, John R Atack, Peter Blurton, et al.
Journal of Medicinal Chemistry|October 9, 2013
Structure-activity-relationship studies around the 2-amino group and pyridine core of antimalarial 3,5-diarylaminopyridines lead to a novel series of pyrazine analogues with oral in vivo activityYassir Younis, Frederic Douelle, Diego González Cabrera, et al.
Pharmacoeconomics|December 23, 2017
Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30Madeleine T King, Rosalie Viney, A Simon Pickard, et al.
Journal of Medicinal Chemistry|June 17, 2021
Benzoheterocyclic Oxime Carbamates Active against <i>Mycobacterium tuberculosis</i>: Synthesis, Structure-Activity Relationship, Metabolism, and Biology TriagingRenier van der Westhuyzen, Amanda Mabhula, Paul M Njaria, et al.
Journal of Psychopharmacology (Oxford, England)|February 12, 2010
MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humansJ R Atack, K A Wafford, L J Street, et al.
Journal of Medicinal Chemistry|March 19, 2004
3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1Robert W Carling, Kevin W Moore, Leslie J Street, et al.
Journal of Medicinal Chemistry|February 27, 2014
Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1Claire Le Manach, Diego Gonzàlez Cabrera, Frederic Douelle, et al.
Bioorganic & Medicinal Chemistry|November 3, 2015
Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterizationCandice Soares de Melo, Soares de Melo Candice, Tzu-Shean Feng, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2018
Synthesis and biological evaluation of aryl-oxadiazoles as inhibitors of Mycobacterium tuberculosisMaria Angeles Martinez-Grau, Isabel C Gonzalez Valcarcel, Julie V Early, et al.
Journal of Medicinal Chemistry|April 16, 2004
Selective, orally active gamma-aminobutyric acidA alpha5 receptor inverse agonists as cognition enhancersFrancine Sternfeld, Robert W Carling, Richard A Jelley, et al.
Pageof 25